Atul Pande, Director at Immunovant, Inc. (IMVT), bought 5,000 shares at $7.98 ($40K) on 2021-08-13, disclosed to the SEC on 2021-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| IMVT | SELL | 2026-06-26 | $57K | — | Filing → |
| IMVT | SELL | 2026-06-16 | $51K | — | Filing → |
| IMVT | SELL | 2026-05-20 | $192K | — | Filing → |